| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/25/2003 | CA2099841C Expression of recombinant proteins in attenuated bacteria |
| 02/25/2003 | CA2048910C Antimicrobial peptides active against plant pathogens, their method of use and various screening methods pertaining thereto |
| 02/25/2003 | CA2032059C Wound treatment employing biologically active peptides |
| 02/25/2003 | CA1341422C Retinoic acid receptor composition and method |
| 02/24/2003 | CA2394973A1 Mutants of bone morphogenetic proteins |
| 02/22/2003 | CA2355573A1 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014724A1 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014702A2 Uses of mammalian cytokine; related reagents |
| 02/20/2003 | WO2003014376A2 Sugar and lipid metabolism regulators in plants iii |
| 02/20/2003 | WO2003014373A2 Metal-binding proteins |
| 02/20/2003 | WO2003014367A1 Method for purification of viral vectors having proteins which bind sialic acid |
| 02/20/2003 | WO2003014365A2 Plant glycogenin homologs and use thereof in starch modification |
| 02/20/2003 | WO2003014364A1 Method for influencing the acceptance of minerals in transgenic plants |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014353A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | WO2003014352A2 Nucleic acids for aminocoumarin biosynthesis |
| 02/20/2003 | WO2003014351A2 Stress-associated genetic products from ashbya gossypii |
| 02/20/2003 | WO2003014350A1 Novel rice gene regulating salt stress tolerance |
| 02/20/2003 | WO2003014349A1 Bifactorial endosperm box, trans-activating factor that binds thereto, and method of regulation of promoter activity |
| 02/20/2003 | WO2003014348A1 Dna molecules from maize and methods of use thereof |
| 02/20/2003 | WO2003014347A2 Plant seed specific promoters |
| 02/20/2003 | WO2003014345A1 Gene panel participating in liver astrocyte activation |
| 02/20/2003 | WO2003014327A2 Stress-related polynucleotides and polypeptides in plants |
| 02/20/2003 | WO2003014326A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/20/2003 | WO2003014323A2 Human smooth muscle myosin heavy chain |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014318A2 Methods for treating diabetes and other blood sugar disorders |
| 02/20/2003 | WO2003014314A2 13 human secreted proteins |
| 02/20/2003 | WO2003014310A2 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 02/20/2003 | WO2003014308A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 02/20/2003 | WO2003014303A2 Molecular interactions in cells |
| 02/20/2003 | WO2003014298A2 Full-length prostate selective polynucleotides and polypeptides |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014293A2 Novel polypeptide analogs and fusions and their methods of use |
| 02/20/2003 | WO2003014160A2 Cd44 variants carrying heparan sulfate chains and uses thereof |
| 02/20/2003 | WO2003014159A1 Methods of screening based on the egf receptor crystal structure |
| 02/20/2003 | WO2003014158A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | WO2003014157A2 Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) |
| 02/20/2003 | WO2003014156A2 NEUREGULIN-β ISOFORMS ASSOCIATED WITH NEURONAL PROCESSES |
| 02/20/2003 | WO2003014155A2 Labelled conjugates of p17 protein and their use in aids diagnosis |
| 02/20/2003 | WO2003014154A2 Vaccines against kaposi's sarcoma-associated herpesvirus |
| 02/20/2003 | WO2003014153A2 Cellular virus receptors and methods of use. |
| 02/20/2003 | WO2003014152A2 Phosphatidylinositol 5-phosphate-binding proteins |
| 02/20/2003 | WO2003014151A2 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | WO2003014150A2 Fusion proteins for insect control |
| 02/20/2003 | WO2003014149A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 02/20/2003 | WO2003014146A1 A novel peptide p1 inhibiting differentiation of osteoclasts |
| 02/20/2003 | WO2003014144A2 Molecule |
| 02/20/2003 | WO2003014140A1 Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer |
| 02/20/2003 | WO2003014078A2 Muc7d1 peptides as antifungal and antibacterial agents |
| 02/20/2003 | WO2003014077A2 Crystal forms and mutants of rank ligand |
| 02/20/2003 | WO2003014076A2 Bi-directional synthesis of oligoguanidine transport agents |
| 02/20/2003 | WO2003013599A2 Anti-coronavirus vaccine |
| 02/20/2003 | WO2003013598A2 Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases |
| 02/20/2003 | WO2003013597A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013575A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 02/20/2003 | WO2003013574A1 Melanin-concentrating hormone antagonists |
| 02/20/2003 | WO2003013573A1 Polypeptide conjugates with extended circulating half-lives |
| 02/20/2003 | WO2003013570A1 Platelet-derived growth factor protection of cardiac myocardium |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2003013426A2 Multivalent synthetic vaccine for cancer |
| 02/20/2003 | WO2003013425A2 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 02/20/2003 | WO2003013266A1 Method for the preparation of gliadin-and glutenin-rich fractions out of gluten in an aqueous medium and in the presence of an acid |
| 02/20/2003 | WO2003013229A2 An animal model for parkinson's disease |
| 02/20/2003 | WO2003013228A2 Biochemistry-related polynucleotides and polypeptides in plants |
| 02/20/2003 | WO2003013227A2 Yield-related polynucleotides and polypeptides in plants |
| 02/20/2003 | WO2003013224A2 Herbicide tolerant cotton plants and methods for producing and identifying same |
| 02/20/2003 | WO2003000851A3 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 02/20/2003 | WO2002103060A9 Enterovirus nucleic acids and methods for detecting enterovirus |
| 02/20/2003 | WO2002099062A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 02/20/2003 | WO2002098900A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/20/2003 | WO2002098369A3 Mutant forms of cholera holotoxin as an adjuvant |
| 02/20/2003 | WO2002098360A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 02/20/2003 | WO2002094980A3 Phytocystatin |
| 02/20/2003 | WO2002094874A3 Internalisation of virus into cells |
| 02/20/2003 | WO2002094862A3 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/20/2003 | WO2002094200A3 Pulmonary administration of chemically modified insulin |
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 02/20/2003 | WO2002092758A8 Gastrokines and derived peptides including inhibitors |
| 02/20/2003 | WO2002090924A3 Mutation induced optimization of receptor signal to noise ratio |
| 02/20/2003 | WO2002083849A3 Vascular endothelial growth factor 2 |
| 02/20/2003 | WO2002083733A3 Polynucleotides and polypeptides of the ifnalpha-6 gene |
| 02/20/2003 | WO2002083080A3 Method of treating arthritis using lentiviral vectors in gene therapy |
| 02/20/2003 | WO2002081621A3 Vaccine against the nile fever virus |
| 02/20/2003 | WO2002079423A3 Delta opioid receptor disruptions, compositions and methods related thereto |
| 02/20/2003 | WO2002078621A3 Replication-competent recombinant virus and methods of use thereof |
| 02/20/2003 | WO2002074953A3 Gene library and a method for producing the same |
| 02/20/2003 | WO2002074931A3 Inhibitors and disassemblers of fibrillogenesis |
| 02/20/2003 | WO2002074331A3 Mutated mhc molecules for use in immune suppression |
| 02/20/2003 | WO2002074156A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/20/2003 | WO2002068673A3 Hin-1, a tumor suppressor gene |
| 02/20/2003 | WO2002068645A8 Compositions and methods relating to breast specific genes and proteins |
| 02/20/2003 | WO2002068607A3 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 02/20/2003 | WO2002068605A3 Non-oligomerizing tandem fluorescent proteins |
| 02/20/2003 | WO2002066505A3 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 02/20/2003 | WO2002064556A3 Complex carbohydrate arrays and methods for the manufacture and uses thereof |
| 02/20/2003 | WO2002064021A3 Methods and compositions for control of bone formation via modulation of ciliary neurotrophic factor activity |